At Ferraro Law, our dedicated attorneys have decades of experience advocating for individuals harmed by defective or dangerous drugs. In recent years, lawsuits involving Zantac® and generic ranitidine products have alleged contamination with a probable human carcinogen known as N-nitrosodimethylamine (NDMA). While we are no longer accepting cases related to Zantac® or ranitidine, we remain committed to helping individuals affected by other harmful pharmaceuticals and continue to provide legal guidance for those navigating complex drug-related claims.
Understanding Zantac® Litigation
Understanding Zantac® Litigation
Zantac®, introduced to reduce excess stomach acid and treat conditions like acid reflux, gastroesophageal reflux disease (GERD), and related ailments, became one of the world’s most popular heartburn medications. Unfortunately, plaintiffs now allege that NDMA contaminated ranitidine in dangerous amounts, significantly elevating patients’ cancer risk.
As a result, multiple courts—including federal Zantac® lawsuits and cases in various state courts such as California state court, Illinois state court, and Delaware trial court—have heard claims of NDMA contamination causing serious cancers like:
- Stomach Cancer
- Kidney Cancer
- Colorectal Cancer
- Liver Cancer
Ranitidine molecule instability is suspected to form NDMA, a known carcinogen, which has led to a wide array of diagnoses. Since many individuals relied on Zantac® (also sold as Zantac® OTC) or generic drug makers’ ranitidine products for acid reflux or heartburn, the litigation has grown into a national concern.
Major pharmaceutical companies, including Zantac® manufacturer GlaxoSmithKline and Boehringer Ingelheim Pharmaceuticals, face lawsuits alleging negligence in failing to ensure their ranitidine drugs were safe.
40 Years Of Fierce Representation
40 Years Of Fierce Representation
Ferraro Law has been committed to holding large corporations and pharmaceutical manufacturers accountable for the harm they cause to innocent consumers. With decades of experience in product liability law, we have earned a reputation as relentless advocates for justice. Over the years, we have built a national reputation for challenging Big Pharma through mass tort and multidistrict litigation (MDL), secured billions of dollars in settlements and verdicts in product liability cases—including lawsuits involving defective medications—and aggressively advocated for cancer patients who trusted pharmaceuticals to be safe but instead faced devastating diagnoses.
How We have helped
How We have helped
Personalized Case Assessment
Ferraro Law has previously supported individuals who developed cancer after taking Zantac® or generic ranitidine by reviewing their medical history, cancer diagnosis, and potential exposure to NDMA contamination. Our assessments aimed to determine whether a connection existed between the use of these medications and their health outcomes.
Comprehensive Evidence Gathering
Our attorneys gathered relevant medical records, pharmacy documentation, and scientific data to evaluate claims involving Zantac® and cancer risk. We worked to identify potentially liable parties, including manufacturers of both brand name and generic ranitidine products.
Nationwide Reach & Pharmaceutical Litigation Experience
Whether clients were part of the federal Zantac® MDL, involved in state court proceedings, or pursuing individual claims, we provided strategic guidance through the litigation process. Our team remained informed on court rulings, scientific findings, and trial developments related to NDMA exposure and its alleged link to cancer.
Contingency-Based Representation
During our time handling Zantac-related claims, we offered contingency-based legal services to help reduce financial barriers for those coping with serious health diagnoses. Clients owed no legal fees unless compensation was recovered on their behalf.
Compassionate Guidance
Receiving a cancer diagnosis after relying on a common heartburn medication can be overwhelming. We provided clients with empathetic legal support while helping them understand their options. Although we are no longer accepting Zantac® cases, we continue to assist individuals affected by other harmful pharmaceuticals and remain a source of legal clarity for those exploring their next steps.
What We Have Handled
What We Have Handled
Ferraro Law has previously represented individuals who developed serious health conditions after using Zantac® or generic ranitidine.
Our work in this area included:
Zantac® Lawsuit Claims & NDMA Contamination
We supported clients who were diagnosed with cancers such as bladder, prostate, and other forms potentially linked to NDMA-contaminated ranitidine products.
Brand Name Zantac® & Generic Ranitidine Cases
Whether the medication was brand name or generic, we evaluated claims involving cancer diagnoses associated with long-term ranitidine use.
Zantac® Class Action Lawsuit & MDL
Our team closely followed developments in the Zantac® multidistrict litigation (MDL), including bellwether trials and judicial updates, to help clients determine the best legal route for their situation.
Future Zantac® Lawsuits & Settlements
While actively handling Zantac-related claims, we monitored court rulings and potential settlement discussions to position our clients for the most informed outcomes.
Dangerous Drugs: Compensation for Victims
Dangerous Drugs: Compensation for Victims
A successful Zantac® cancer lawsuit aimed to secure compensation for the financial and emotional hardships you’ve faced—past, present, and future.
Compensation covered:
Medical Expenses
Covered the costs of treatments like chemotherapy, surgery, and ongoing care for bladder cancer, kidney cancer, prostate cancer, or other related diagnoses.
Lost Wages & Future Earnings
Addressed the financial burden of lost income due to your illness, as well as the reduction in future earning capacity caused by your diagnosis, providing financial support during this challenging time.
Pain & Suffering
Recognized the emotional trauma and physical suffering caused by your cancer diagnosis, as well as the profound impact it had on your quality of life and the ongoing challenges of navigating treatments and their side effects.
Wrongful Death
For families grieving the loss of a loved one to Zantac-related cancer, compensation covered funeral and burial expenses as well as damages for the loss of companionship and emotional support.
Frequently Asked Questions (FAQs)
Frequently Asked Questions
01.
Is Ferraro Law still accepting cases for Zantac®?
No, Ferraro Law is no longer accepting Zantac-related cases. If you believe you have a claim, consider reaching out to a lawyer currently handling Zantac® lawsuits to discuss your options and next steps.
02.
Does taking generic ranitidine raise the same cancer risk as brand name Zantac®?
Yes. Many Zantac® lawsuits allege that generic ranitidine manufacturers failed to prevent NDMA contamination and protect consumers, making them liable alongside brand name Zantac® companies.
03.
How do I know if my cancer is linked to ranitidine molecule instability?
We consult with medical experts who review your condition, usage timeline, and scientific data on NDMA. If the facts support a cancer diagnosis as a result of Zantac® use, you could have a valid claim.
04.
Are there any ongoing Zantac® settlements or trials?
Numerous Zantac® lawsuits are consolidated into MDL, which are currently on appeal. We stay updated on any court rulings regarding NDMA contamination and future Zantac® lawsuits.
05.
What if I took Zantac® years ago but only recently developed cancer?
Many times, cancer develops slowly. If you have a medical record linking your condition to NDMA-contaminated ranitidine, you might still file a claim. We’ll review your documentation to determine eligibility.
have more questions?
glossary of key terms
glossary of key terms
Zantac® (Ranitidine)
A heartburn medication designed to reduce stomach acid production, now under scrutiny for NDMA contamination.
NDMA (N-Nitrosodimethylamine)
A probable human carcinogen found in certain ranitidine drugs.
Zantac® MDL
Multidistrict litigation consolidating federal Zantac® lawsuit cases to streamline pretrial proceedings.
Generic Ranitidine Manufacturers
Companies producing ranitidine products not under the brand name Zantac®.
Boehringer Ingelheim Pharmaceuticals
One of the corporations alleged to have manufactured or sold NDMA-contaminated ranitidine.
Understanding Your Next Steps
Understanding Your Next Steps
If you or a loved one has been diagnosed with bladder cancer, colorectal cancer, or another form of cancer following the use of Zantac® or ranitidine, it’s important to stay informed about the current state of the litigation. While Ferraro Law is no longer accepting new Zantac-related cases, we encourage individuals to consult with a qualified attorney to determine whether they may still have legal options. Staying up to date on settlement developments and deadlines can help you make informed decisions about how to proceed.
